Skip Navigation


Rheumatology Advance Access originally published online on March 1, 2005
Rheumatology 2005 44(7):829-830; doi:10.1093/rheumatology/keh585
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/7/829    most recent
keh585v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Birrell, F.
Right arrow Articles by Doherty, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Birrell, F.
Right arrow Articles by Doherty, M.
Related Collections
Right arrow Osteoarthritis and Cartilage
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

EDITORIAL

Is it time for more rheumatologists to embrace osteoarthritis?

F. Birrell, N. K. Arden1, P. G. Conaghan3, C. Cooper2, P. Dieppe4 and M. Doherty5

Musculoskeletal Research Group, University of Newcastle upon Tyne, Rheumatology, Wansbeck General Hospital and Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne, 1 MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, 2 MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, Southampton, 3 Academic Unit of Musculoskeletal Disease and Rehabilitation, University of Leeds, Leeds General Infirmary, Leeds, 4 MRC Health Services Research Collaboration, University of Bristol, Bristol and 5 Academic Rheumatology, University of Nottingham, Nottingham City Hospital, Nottingham, UK

Correspondence to: F. Birrell, 4th Floor, Cookson Building, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK. E-mail: Fraser.Birrell@ncl.ac.uk

The first 10% of the full text of this article appears below.

There has been a degree of apathy or even antipathy towards osteoarthritis (OA) by UK rheumatologists, the origin of which is hard to elucidate. Clinical research in OA has historically not been regarded as the highest priority by UK funding bodies [1]. The paucity of evidence-based therapy, particularly disease-modifying OA drugs (DMOADs), may have led to OA patients being a source of frustration for clinicians whose clinics are already bulging in addressing the challenges of inflammatory arthritis. The previous attempts of enthusiasts . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?